These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13557188)

  • 21. The choice of estrogen preparations in the treatment of prostatic cancer.
    Morales A; Pujari B
    Can Med Assoc J; 1975 Nov; 113(9):865-7. PubMed ID: 1182631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histopathology of prostate cancer under hormone therapy].
    RUPPERT H
    Z Urol; 1953; 46(7):443-56. PubMed ID: 13103640
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cancer of the prostate. Morbidity and mortality with estrogen therapy].
    Ous S; Fryjordet A; Waaler G
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):748-51. PubMed ID: 4830337
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormone therapy of cancer.
    HINES DC
    Pa Med J; 1951 Nov; 54(11):1045-51. PubMed ID: 14891353
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hormonal treatment of prostatic disorders].
    DARGET R
    Maroc Med; 1951 Aug; 30(315):733-6. PubMed ID: 14881736
    [No Abstract]   [Full Text] [Related]  

  • 26. [Estrogen therapy for prostatic cancer].
    Shida K; Shimazaki J; Kurihara H; Ito Z
    Horumon To Rinsho; 1966 Jun; 14(6):457-64. PubMed ID: 5336362
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic side-effects of estrogen therapy for prostatic cancer.
    Kontturi M
    Scand J Urol Nephrol Suppl; 1991; 138():127-30. PubMed ID: 1784996
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of cancer of the prostate].
    BOUCHARD R
    Prog Med (Paris); 1955 Nov; 83(21):376-80. PubMed ID: 13289919
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heteronymic hormone therapy in the management of prostate cancer].
    MANNEL J
    Ther Umsch; 1952 Mar; 8(12):176-82. PubMed ID: 14950782
    [No Abstract]   [Full Text] [Related]  

  • 30. Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancer.
    Vetto JT; Beer TM; Fidda N; Ham B; Jimenez-Lee R; Schmidt W
    Diagn Cytopathol; 2004 Dec; 31(6):417-9. PubMed ID: 15540181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stricture of the anterior urethra following estrogen therapy in patients with prostatic cancer.
    Yokoyama M; Fukutani K; Kawamura T; Shoji F; Ohtani M
    Urol Int; 1983; 38(4):247-50. PubMed ID: 6308871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional state of the adrenal cortex in cancer and adenoma of the prostate in the process of estrogen therapy].
    Klepikov FA; Genes SG; Popova SS
    Urol Nefrol (Mosk); 1972; 37(6):38-42. PubMed ID: 4124660
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical studies on serum lipids in the patients with tumor of the prostate gland. 3rd report: changes of serum lipid peroxide levels during estrogen therapy for prostatic cancer and therapeutic and preventive effect of riboflavin tetrabutylate for hyperlipidemia].
    Shimada M; Iguchi H; Yoshida H; Imamura K
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2107-12. PubMed ID: 6677793
    [No Abstract]   [Full Text] [Related]  

  • 34. [Remote results of controlled estrogen therapy of prostatic cancer].
    Dunaevskiĭ IaL; Shapiro SB
    Urol Nefrol (Mosk); 1974; 39(4):59-61. PubMed ID: 4410732
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
    Ablin RJ
    Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined estrogen & cortisone therapy in prostate carcinomas].
    ANELLO A
    Minerva Urol; 1959; 11(3):116-9. PubMed ID: 13674313
    [No Abstract]   [Full Text] [Related]  

  • 37. [Massive estrogen therapy & combined radiotherapy in carcinoma of the prostate].
    DE LA PENA A; VALDES R
    Rev Clin Esp; 1958 Mar; 68(6):362-7. PubMed ID: 13568266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of prostate carcinoma].
    ZIMMER W
    Klin Med Osterr Z Wiss Prakt Med; 1954 Oct; 9(10):440-4. PubMed ID: 13222728
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy.
    Wibowo E; Schellhammer P; Wassersug RJ
    J Urol; 2011 Jan; 185(1):17-23. PubMed ID: 21074215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy.
    Konishi N; Nakaoka S; Hiasa Y; Kitahori Y; Ohshima M; Samma S; Okajima E
    Oncology; 1993; 50(4):259-63. PubMed ID: 7684519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.